Rule · NAMFISA · 24 Mar 2020

Notice Declaration of Undesirable Practice: Curtailment of COVID-19 Benefit Use

The Registrar of Medical Aid Funds declares the curtailment of benefits for COVID-19 diagnostic testing and treatment as an undesirable practice under section 4(9) of the Medical Aid Funds Act, 1995. This prohibition applies to medical aid funds that require members to pay upfront for tests or refund payments only upon positive results. Funds are required to ensure members meeting WHO criteria have access to testing and recommended healthcare within their benefit limits. Any contravention of this notice will be addressed according to the Act's provisions.

NamibiaNamibia Financial Institutions Supervisory Authority

More like this from NAMFISA

We email you every new NAMFISA publication the day it's published.

Source: Namibia Financial Institutions Supervisory Authority — original document · Summary generated with machine assistance and reviewed before publication; the authoritative text is the regulator's original document. How RegAlert works

In RegAlert: added · updated